An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B

Abstract

We identified an intrahepatic transcriptional signature associated with enhanced immune activation which predicts therapy response. These novel associations could lead to better understanding of responsiveness to peginterferon in CHB patients, and may assist in selecting possible responders to interferon-based treatment.